PFE: Pfizer Inc. Stock

by  •  • Comments Off on PFE: Pfizer Inc. Stock

SIC 2834 – Pharmaceutical Preparations

Valuation
Market Cap ($M) 216,497.52
Enterprise Value ($M) 250,763.52
Book Value ($M) 95,917.00
Book Value / Share 16.99
Price / Book 2.26
NCAV ($M) -44,303.00
NCAV / Share -7.85
Price / NCAV -4.89

Profitability (mra)
Return on Invested Capital (ROIC) 0.21
Return on Assets (ROA) 0.16
Return on Equity (ROE) 0.38

Liquidity (mrq)
Quick Ratio 1.11
Current Ratio 1.37

Balance Sheet (mrq) ($M)
Current Assets 50,078.00
Assets 195,617.00
Liabilities 94,381.00
Debt n/a
Equity n/a

Income Statement (mra) ($M)
Revenue 100,330.00
Operating Income 38,870.00
Net Income 31,372.00
Earnings Per Share Diluted n/a
Earnings Per Share Basic n/a

Cash Flow Statement (mra) ($M)
Cash From Operations 29,267.00
Cash from Investing -15,783.00
Cash from Financing -14,834.00

(click for more detail)

File Date Form Activist 13D/G Investors Ownership
(%)		 Change
(%)
02-09 13G/A Vanguard Group Inc 8.94 7.82
02-07 13G/A State Street Corp 5.08 -0.29
02-03 13G/A BlackRock Inc. 7.90 8.02

Top 13F Investors Shares
(1000)		 Change
(%)		 Value
($1000)		 Change
(%)

(click for more detail)

Date Insider Trades Code Shares Value

(click for more detail)
Short Volume
Market Date Short Volume Total Volume Short Volume Ratio
2023-06-02 2,230,092 22,736,353 9.81
2023-06-01 2,815,783 20,256,137 13.90
2023-05-31 3,916,399 46,166,333 8.48
2023-05-30 2,639,804 24,371,098 10.83

(click for more detail)

Similar Companies
NUVB – Nuvation Bio Inc – Class A OGN – Organon & Co.
PBH – Prestige Consumer Healthcare Inc PRGO – Perrigo Company plc
QGEN – Qiagen NV


Financial data and stock pages provided by
Fintel.io